Securities Class Actions
Securities Law Class Actions, Investigations and Alerts
Securities class action lawsuits are filed on behalf of a large number of investors who suffered financial losses in a certain security or stock. Oftentimes, securities class actions are initiated due to fraudulent stock manipulation, the distribution of false or misleading information to shareholders, or other violations of securities laws. Through the filing of securities class action lawsuits, a group of investors have the opportunity the recover compensation for losses resulting from fraudulent activity.
Securities fraud occurs when a corporation misleads their investors about the value of their securities by manipulating accounts, misstating earnings or making other misrepresentations which result in an increase in stock price. Eventually, the fraud will be detected, and investors who suffered damages as a result may have legal recourse through a securities class action. Some common allegations posed in securities lawsuits include pricing violations, churning and improper execution of trades.
If you suspect you have been subjected to a form of securities fraud, you may have legal recourse to recover any resulting damages. To learn more about your legal rights as an investor, fill out our free, no obligation case review form.
The attorneys working with ClassAction.org are investigating potential claims that could affect investors who purchased Abiomed common stock.
The attorneys working with ClassAction.org would like to hear from Hewlett-Packard (HP) shareholders in light of news regarding a recent $8.8 million accounting scandal.
The attorneys working with our website want to hear from shareholders of Capital One to determine whether a shareholder derivative action can be brought against the bank's board of directors for wrongful billing practices.
A Groupon class action lawsuit has been filed against the world's largest online coupon website alleging that it misled investors.
Accretive Health, Inc. has been hit with a class action lawsuit alleging that it made false and misleading statements to investors.
A class action lawsuit has been filed against Nevsun alleging that it issued false and misleading information in connection with its gold reserves in its Bisha Mine.
An Amylin Pharmaceutical shareholder may be able to file an action seeking to enjoin the proposed merger of Amylin Pharmaceuticals and Bristol-Meyers Squibb claiming that because the price is too low the process is flawed.
A class action lawsuit has been filed on behalf of investors who purchased Gold Resource Corp. common stock between Jan. 30, 2012 and Oct. 17, 2012.